Primary Frozen Shoulder
Conditions
Interventions
Sponsors
Shenzhen Second People's Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Age 40-60 years. 2. Diagnosed with frozen shoulder by history, physical examination and imaging examination, with the duration of the disease ranging from 3 to 12 months, and the effect of oral medication is not satisfactory; at the time of admission, shoulder pain and limitation of shoulder joint movement are obvious, with VAS score >= 5 and AROM score < 25. 3. No significant abnormalities in the test results of routine shoulder joint X-ray, coagulation function and blood routine. 4. Patients fully understood the purpose of the study, understood the possible accidents and risks during anesthesia and injection needle knife release, signed the informed consent form, and were willing to provide complete information and cooperate with the completion of follow-up.
Exclusion criteria
Exclusion criteria: 1. Those with complete tendon ruptures or shoulder dislocations or humeral head fractures that are not suitable for conservative treatment as evidenced by ultrasound and other imaging studies. 2. Previous trauma or surgery to the shoulder. Combined with other diseases of the shoulder joint, such as tumors, severe osteoporosis, autoimmune system diseases, etc. 3. Combined with serious circulatory, digestive, urological and other medical system diseases. 4. Those who suffer from psychosomatic and other diseases that prevent them from cooperating. 5. Patients with skin breakdown, ulceration or infection at the anesthesia puncture site, and patients with chronic fever. 6. Those who are allergic to anesthetic drugs. 7. Pregnant and lactating women. 8. Those who are currently participating in other clinical trials. 10. Other conditions that, in the opinion of the investigator, are not appropriate for inclusion in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| visual analogue scale, VAS;active range of motion, AROM;Constant-Murley score, CMS;inferior capsule thickness, ICT;coracohumeral ligament, CHL;glenohumeral distance, GHD; | — |
Countries
China
Contacts
Public ContactLi Zhenzhou, Zhou Biqiang
Shenzhen Second People's Hospital
Outcome results
None listed